Health Catalyst, Inc. (NASDAQ:HCAT) Insider Linda Llewelyn Sells 6,442 Shares

Health Catalyst, Inc. (NASDAQ:HCAT) insider Linda Llewelyn sold 6,442 shares of the business’s stock in a transaction that occurred on Wednesday, January 15th. The shares were sold at an average price of $5.80, for a total transaction of $37,363.60. Following the completion of the sale, the insider now directly owns 92,260 shares in the company, valued at approximately $535,108. This trade represents a 6.53 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Linda Llewelyn also recently made the following trade(s):

• On Monday, December 16th, Linda Llewelyn sold 6,442 shares of Health Catalyst stock. The shares were sold at an average price of $7.88, for a total transaction of $50,762.96.

Health Catalyst Trading Down 0.2 %

Shares of HCAT opened at $5.49 on Friday. The firm has a market cap of $334.06 million, a price-to-earnings ratio of -4.07 and a beta of 1.36. The firm has a 50 day moving average price of $7.61 and a 200-day moving average price of $7.52. Health Catalyst, Inc. has a fifty-two week low of $5.35 and a fifty-two week high of $10.99. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.41 and a current ratio of 1.41.

Health Catalyst (NASDAQ:HCAT) last announced its quarterly earnings data on Wednesday, November 6th. The company reported $0.07 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.10 by ($0.03). Health Catalyst had a negative net margin of 26.20% and a negative return on equity of 7.51%. The company had revenue of $76.40 million for the quarter, compared to the consensus estimate of $76.27 million. During the same period last year, the business posted ($0.22) earnings per share. The firm’s quarterly revenue was up 3.5% compared to the same quarter last year. As a group, equities research analysts forecast that Health Catalyst, Inc. will post -0.33 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on HCAT shares. Stephens boosted their price target on shares of Health Catalyst from $7.00 to $9.00 and gave the company an “equal weight” rating in a research report on Thursday, November 14th. Citigroup reduced their target price on Health Catalyst from $10.50 to $10.00 and set a “buy” rating for the company in a research report on Friday, January 10th. Royal Bank of Canada lowered their price target on Health Catalyst from $9.00 to $7.00 and set a “sector perform” rating on the stock in a report on Wednesday. Evercore ISI boosted their price objective on Health Catalyst from $8.00 to $10.00 and gave the stock an “outperform” rating in a report on Tuesday, October 8th. Finally, Piper Sandler reiterated an “overweight” rating and set a $12.00 target price (up from $11.00) on shares of Health Catalyst in a research report on Tuesday, November 26th. Two research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to MarketBeat, Health Catalyst presently has an average rating of “Moderate Buy” and a consensus price target of $11.27.

Hedge Funds Weigh In On Health Catalyst

Large investors have recently bought and sold shares of the stock. Quest Partners LLC bought a new position in shares of Health Catalyst in the third quarter worth approximately $34,000. Quarry LP boosted its position in Health Catalyst by 59.4% during the 2nd quarter. Quarry LP now owns 7,002 shares of the company’s stock valued at $45,000 after buying an additional 2,610 shares during the period. nVerses Capital LLC bought a new stake in Health Catalyst in the 3rd quarter worth $59,000. Mackenzie Financial Corp bought a new stake in Health Catalyst in the 2nd quarter worth $70,000. Finally, Quadrature Capital Ltd purchased a new position in shares of Health Catalyst in the third quarter valued at about $84,000. 85.00% of the stock is owned by hedge funds and other institutional investors.

Health Catalyst Company Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.